News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Daniela Schiller, PhD

Articles by Daniela Schiller, PhD

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?

Telling Humanity’s Brain Story: Insights From Brain Capital

ByHarris A. Eyre, MD, PhD,Robert M. Lundin, BSc, MBBCh,Shuo Chen, JD,Ryan Abbott, MD, JD, PhD,Shekhar Saxena, MD,Stephen T. C. Wong, PhD,James T. Hackett,William Hynes, DPhil,Daniela Schiller, PhD,Nancy Mannix, JD,Serena Jenkins, PhD,Claire Neihaus, MSc,Walter D. Dawson, DPhil,Michael Berk, MD, PhD

January 19th 2023

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?

Latest Updated Articles

Telling Humanity’s Brain Story: Insights From Brain Capital
January 19th 2023

Trending on Psychiatric Times

Dose Lithium Once a Day at Night: An Update

Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD

Addressing Sexual Wellness: A Psychiatric Perspective

Consensus on Overcoming Barriers to Long-Acting Injectable Use in Schizophrenia

Understanding the Complexities of Suicide Risk: A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD